Scientific job: CLAIMED. This article owns the public clinical movement from fertility question → time/age/reproductive history → male + female evaluation → identified or unexplained factor → evidence-based treatment → assisted reproduction where appropriate → pregnancy / no pregnancy / fertility preservation / alternative pathway → follow-up. It does not own reproductive biology, pregnancy care, genetics or endocrinology mechanisms.

Wait, what? Infertility is not automatically a “women’s problem”.

WHO defines infertility as a disease of the male or female reproductive system and notes that infertility can arise from male factors, female factors, a combination of both or remain unexplained. That immediately changes the architecture: the clinically useful receiver is often the couple or reproductive pair, not one presumed patient.

This is why a good fertility pathway evaluates both sides of reproduction where relevant instead of routing every problem into gynaecology alone.

The fertility-care tube

Fertility goal → time trying / age / history → male + female assessment → targeted testing → cause identified / unexplained → treatment options → IUI / IVF / ICSI / surgery / medical treatment / preservation where appropriate → pregnancy or other outcome → obstetric or follow-up handoff.

The route is not linear for everyone. Some patients need earlier investigation because of age, menstrual irregularity, known reproductive disease, previous cancer treatment, genetic risk or other clinical factors. Others may need counselling or fertility preservation before attempting conception.

1. Time matters, but the 12-month definition is not a universal waiting rule

WHO’s clinical definition uses failure to achieve pregnancy after 12 months or more of regular unprotected sexual intercourse. But WHO also recognises that fertility interventions may begin earlier based on medical, sexual and reproductive history, age, physical findings and diagnostic testing.

For eduKateAI, this creates an important gate: definition threshold ≠ mandatory delay before assessment.

2. Fertility testing is not population screening

Tests such as AMH or FSH can be useful in particular clinical contexts, but they are not equivalent to general population screening for future fertility. Singapore MOH stated in May 2026 that AMH and FSH are used when clinically indicated, including prior to assisted reproduction, and are not part of universal Healthier SG screening.

This is exactly the distinction the Medicine Web needs: fertility test ≠ population screening programme. Preventive Medicine owns population screening logic; Reproductive Medicine owns clinically indicated fertility assessment.

3. Evaluation is bilateral and problem-specific

Potential causes can include ovulation disorders, tubal disease, uterine conditions, endometriosis, endocrine disorders, sperm number or function problems, sexual dysfunction, prior treatment effects and combinations of factors. Some couples remain unexplained after standard evaluation.

NUH’s current Reproductive Endocrinology and Infertility service explicitly describes a multidisciplinary model addressing both male and female contributors, including ovulation problems, tubal disease, endometriosis, PCOS, uterine disorders, low sperm count/motility, unexplained infertility and recurrent pregnancy loss.

4. A normal test does not prove normal fertility

Reproduction is a system outcome involving gametes, anatomy, timing, fertilisation, embryo development, implantation and pregnancy. One normal laboratory or imaging result cannot certify that every step will succeed.

For eduKateAI, fertility assessment must remain multi-object and probabilistic. A test narrows part of the problem; it does not certify the entire reproductive system.

5. Unexplained infertility is a state, not “nothing is wrong”

When standard investigations do not identify a clear cause, the outcome may be classified as unexplained infertility. That does not mean the difficulty is imaginary or that all biological processes are known to be normal. It means the current evaluation has not found an explanatory factor with the tools used.

This distinction protects uncertainty rather than filling the gap with speculation.

6. Treatment should match the problem and evidence

WHO’s first global infertility guideline, issued in November 2025, covers prevention, diagnosis and treatment across ovulatory dysfunction, tubal and uterine factors, male factors and unexplained infertility. The appropriate treatment can range from addressing an underlying condition to timed interventions, IUI, IVF, ICSI or other assisted reproductive approaches.

The key routing rule is: infertility diagnosis ≠ IVF automatically. Assisted reproduction is one part of fertility care, not its definition.

7. IUI and IVF are different clinical objects

IUI places prepared sperm into the uterus around ovulation and is appropriate only in selected situations. IVF involves ovarian stimulation, egg retrieval, fertilisation in the laboratory and embryo transfer; ICSI may be used when clinically indicated. KKH and NUH both maintain specialised assisted-reproduction services that distinguish these pathways.

For eduKateAI, the procedure name must travel with the indication, age/context, prior treatment, relevant reproductive findings and intended next step.

8. Fertility preservation is a different time horizon

Some people are not currently infertile but face future fertility risk from age, cancer treatment, surgery or other medical circumstances. Cryopreservation of eggs, sperm or embryos can therefore be a preservation pathway rather than a treatment for present infertility.

This is another reason not to collapse reproductive medicine into one IVF route. The clinical question may be preserve future possibility, not achieve pregnancy now.

9. Genetics can enter before embryo transfer

Selected couples with defined inherited conditions may use preimplantation genetic testing under regulated circumstances. Singapore MOH currently lists approved providers for PGT-M and PGT-SR services. The Genetics & Genomic Medicine Web owns variant/inheritance interpretation; Reproductive Medicine owns how that information is used within the fertility pathway.

10. Pregnancy is a handoff, not the end of medicine

A positive pregnancy test changes ownership. Early fertility services may still provide short-term support, but ongoing pregnancy care moves into Obstetrics. The handoff should preserve treatment history, medication exposures, embryo transfer details where relevant, multiple-pregnancy risk and any important genetic or medical context.

For eduKateAI: pregnancy achieved ≠ fertility episode clinically complete until the receiving obstetric pathway has accepted the state.

11. Fertility care also has a human and financial receiver

Infertility can carry emotional distress, stigma, repeated uncertainty, time pressure and financial burden. WHO’s 2025 guideline explicitly calls for safer, fairer and more affordable fertility care. Singapore supports eligible assisted conception procedures through government co-funding and MediSave arrangements, with financing policy still under review in 2026.

Outcome therefore includes more than pregnancy rate. A responsible system preserves patient goals, informed choice, treatment burden, complications, financial exposure and psychological wellbeing.

Characteristic failure modes

• Woman-only error: assuming infertility belongs to the female partner.
• Screening collapse: using fertility biomarkers as universal population screening.
• Single-test certainty: one normal test treated as proof of normal fertility.
• IVF reflex: infertility diagnosis treated as automatic indication for IVF.
• Unexplained = absent error: no identified cause treated as no real problem.
• Age-only error: age used as the entire fertility assessment.
• Pregnancy-endpoint error: positive test treated as the final handoff rather than transition into obstetric care.

The eduKateAI routing contract

• Canonical public owner: Reproductive Medicine & Fertility Web.
• Input state: fertility concern, infertility, fertility-preservation need or assisted-reproduction question.
• Primary job: preserve male + female contributors, clinical indication, test meaning, treatment selection and reproductive outcome through the pathway.
• Do not collapse: infertility ≠ female-factor infertility; fertility test ≠ population screen; unexplained ≠ imaginary; infertility ≠ IVF.
• Handoffs: Obstetrics, Endocrine/Metabolic, Genetics/Genomics, Laboratory Medicine, Urology/Andrology, Surgery, Mental Health and Preventive Medicine.
• Return receipt: cause identified/not identified, treatment chosen, cycle completed, pregnancy achieved/not achieved, preservation completed, complications identified, next reproductive plan accepted.

Authoritative routes

• WHO — Guideline for prevention, diagnosis and treatment of infertility
• WHO — Infertility fact sheet
• Singapore MOH — fertility testing and screening distinction
• Singapore MOH — assisted conception financing
• NUH — Reproductive Endocrinology & Infertility
• KKH — KKIVF Centre

Educational boundary: this article explains fertility-care information architecture. It does not interpret fertility tests, estimate an individual chance of conception, recommend assisted reproduction or give personal reproductive advice.